tetrandrine has been researched along with Pituitary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Hu, Y; Jiang, S; Jiang, Y; Lyu, L; Ma, W; Wang, L; Wang, M; Wang, X; Wang, Z; Ye, F; Yin, S; Zhou, P; Zhou, Y | 1 |
1 other study(ies) available for tetrandrine and Pituitary Neoplasms
| Article | Year |
|---|---|
Autophagy inhibition enhances anti-pituitary adenoma effect of tetrandrine.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Pituitary Neoplasms; Rats | 2021 |